Literature DB >> 6298781

The PHI (PHI-27)/corticotropin-releasing factor/enkephalin immunoreactive hypothalamic neuron: possible morphological basis for integrated control of prolactin, corticotropin, and growth hormone secretion.

T Hökfelt, J Fahrenkrug, K Tatemoto, V Mutt, S Werner, A L Hulting, L Terenius, K J Chang.   

Abstract

By using the indirect immunofluorescence technique, one and the same neuron in the parvocellular part of the paraventricular nucleus has been shown to stain with antisera against three different peptides: PHI (PHI-27), corticotropin-releasing factor (CRF), and enkephalin. This could explain the well-known parallel increase in plasma prolactin, corticotropin, and growth hormone levels--for example, under certain types of stress--as being due to a concomitant release of PHI-like, CRF-like, and enkephalin-like peptides from the same nerve endings in the median eminence. A hypothetical mechanism for the co-ordinated release of these three anterior pituitary hormones is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6298781      PMCID: PMC393488          DOI: 10.1073/pnas.80.3.895

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Effects of methionine-enkephalin on prolactin release and catecholamine levels and turnover in the median eminence.

Authors:  L Ferland; K Fuxe; P Eneroth; J A Gustafsson; P Skett
Journal:  Eur J Pharmacol       Date:  1977-05-01       Impact factor: 4.432

Review 2.  Hypothalamic regulatory hormones.

Authors:  A V Schally; A Arimura; A J Kastin
Journal:  Science       Date:  1973-01-26       Impact factor: 47.728

3.  Corticosterone, prolactin, and growth hormone responses to handling and new environment in the rat.

Authors:  G M Brown; J B Martin
Journal:  Psychosom Med       Date:  1974 May-Jun       Impact factor: 4.312

4.  Structure of the porcine vasoactive intestinal octacosapeptide. The amino-acid sequence. Use of kallikrein in its determination.

Authors:  V Mutt; S I Said
Journal:  Eur J Biochem       Date:  1974-03-01

5.  Studies on the mechanism of the dopamine-mediated inhibition of prolactin secretion.

Authors:  R M MacLeod; J E Lehmeyer
Journal:  Endocrinology       Date:  1974-04       Impact factor: 4.736

6.  Polypeptide with broad biological activity: isolation from small intestine.

Authors:  S I Said; V Mutt
Journal:  Science       Date:  1970-09-18       Impact factor: 47.728

7.  Prolactin releasing factor in porcine and rat hypothalamic tissue.

Authors:  R C Valverde; V Chieffo; S Reichlin
Journal:  Endocrinology       Date:  1972-10       Impact factor: 4.736

8.  Hypothalamic mediation of growth hormone and adrenal stress response in the squirrel monkey.

Authors:  G M Brown; D S Schalch; S Reichlin
Journal:  Endocrinology       Date:  1971-09       Impact factor: 4.736

9.  Identification of two related pentapeptides from the brain with potent opiate agonist activity.

Authors:  J Hughes; T W Smith; H W Kosterlitz; L A Fothergill; B A Morgan; H R Morris
Journal:  Nature       Date:  1975-12-18       Impact factor: 49.962

10.  Modification of stress-induced prolactin release by dexamethasone or adrenalectomy.

Authors:  P G Harms; P Langlier; S M McCann
Journal:  Endocrinology       Date:  1975-02       Impact factor: 4.736

View more
  18 in total

1.  Influence of steroids on the hypothalamic corticotropin-releasing factor and preproenkephalin mRNA responses to stress.

Authors:  S L Lightman; W S Young
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

2.  CRF-containing neurons of the rat hypothalamus.

Authors:  S Daikoku; Y Okamura; H Kawano; Y Tsuruo; M Maegawa; T Shibasaki
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

3.  Peptide-immunoreactive nerves in the mammalian female genital tract.

Authors:  W M Huang; J Gu; M A Blank; J M Allen; S R Bloom; J M Polak
Journal:  Histochem J       Date:  1984-12

4.  Potentiation of the hCRF-induced release of ACTH in man by an opioid antagonist.

Authors:  H Ehrenreich; C Kolmar; O A Müller; F D Goebel
Journal:  Klin Wochenschr       Date:  1987-05-15

5.  The gene encoding vasoactive intestinal peptide is located on human chromosome 6p21----6qter.

Authors:  I Gozes; R Avidor; Y Yahav; D Katznelson; C M Croce; K Huebner
Journal:  Hum Genet       Date:  1987-01       Impact factor: 4.132

6.  Structure and expression of the gene encoding the vasoactive intestinal peptide precursor.

Authors:  S Linder; T Barkhem; A Norberg; H Persson; M Schalling; T Hökfelt; G Magnusson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

7.  Coding sequences for vasoactive intestinal peptide and PHM-27 peptide are located on two adjacent exons in the human genome.

Authors:  M Bodner; M Fridkin; I Gozes
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

8.  Co-expression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat.

Authors:  P E Sawchenko; L W Swanson; W W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

9.  Proenkephalin is processed in a projection-specific manner in the rat central nervous system.

Authors:  J D White; C M Gall; J F McKelvy
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

Review 10.  Neuroendocrine regulation of thyrotropin-releasing hormone (TRH) in the tuberoinfundibular system.

Authors:  R Toni; R M Lechan
Journal:  J Endocrinol Invest       Date:  1993-10       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.